NYSE:LHHealthcare
A Look At Labcorp Holdings (LH) Valuation After Illumina Alliance Puts Precision Oncology In Focus
Illumina alliance puts precision oncology in focus for Labcorp Holdings (LH)
Labcorp Holdings (LH) is back in the spotlight after expanding its collaboration with Illumina to widen access to next generation sequencing based cancer testing and co develop new precision oncology diagnostics.
See our latest analysis for Labcorp Holdings.
For investors, the Illumina alliance arrives as Labcorp's 1-year total shareholder return of 17.09% and 3-year total shareholder return of 44.23% contrast with a...